1 |
Akaike A, Mine Y, Sasa M, Takaori S. Voltage and current clamp studies of muscarinic and nicotinic excitation of the rat adrenal chromaffin cells. J Pharmacol Expt Ther 255: 333-339, 1990
|
2 |
Allal C, Lazartigues E, Tran MA, Brefel-Courbon C, Gharib C, Montastruc JL, Rascol O. Central cardiovascular effects of tacrine in the conscious dog: a role for catecholamines and vasopressine release. Eur J Pharmacol 348: 191-198, 1998
DOI
ScienceOn
|
3 |
Anton AH, Sayre DF. A study of the factors affecting the aluminum oxidetrihydroxy indole procedure for the analysis of catecholamines. J Pharmacol Exp Ther 138: 360-375, 1962
|
4 |
Braga MFM, Harvey AL, Rowan EG. Effects of tacrine, velnacrine (HP029), suronacrine (HP128) and 3,4-diaminopyridine on skeletal neuromuscular transmission in vitro. Br J Pharmacol 102: 909, 1991
DOI
ScienceOn
|
5 |
Elinder F, Mohammed AK, Winblad B, Århem P. Effects of THA on ionic currents in myelinated axons of Xenopus laevis. Eur J Pharmacol 164: 599-602, 1989
DOI
ScienceOn
|
6 |
Freeman SE, Lau WM, Szilagyi M. Blockade of a cardiac K channel by tacrine: interactions with muscarinic and adenosine receptors. Eur J Pharmacol 154: 59, 1988
DOI
ScienceOn
|
7 |
Kiefer-Day JS, Abdallah ESAM, Forray C, Lee NH, Kim ON, El-Fakahany EE. Effects of tacrine on brain muscarinic- receptor- mediated second-messenger signals. Pharmacology 47: 98- 110, 1993
|
8 |
Kitamura N, Ohta T, Ito S, Nakazato Y. Calcium channel subtypes in porcine adrenal chromaffin cells. Pflugers Arch 434: 179-187, 1997
DOI
|
9 |
Knapp MJ, Knopman DS, Solomon PR, Pendlebury WW, Davis CS, Gracon SI. A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. J Am Med Assoc 271: 985-991, 1994
DOI
|
10 |
Lim DY, Hwang DH. Studies on secretion of catecholamines evoked by DMPP and McN-A-343 in the rat adrenal gland. Korean J Pharmacol 27(1): 53-67, 1991
|
11 |
Rogawski MA. Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons. Eur J Pharmacol 142: 169, 1987
DOI
ScienceOn
|
12 |
Savci V, Gurun MS, Gavun S, Ulus IS. Cardiovascular effects of centrally injected tetrahydroaminoacridine in conscious normotensive rats. Eur J Pharmacol 346: 35-41, 1998
DOI
ScienceOn
|
13 |
Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A. Oral tetrahydroaminoacridine in long-term treatment of senile dementia, Alzheimer type. N Engl J Med 315: 1241-1245, 1986
DOI
ScienceOn
|
14 |
Thesleff S, Sellin LC, Taggerud S. Tetrahydroamino-acridine (tacrine) stimulates neurosecretion at mammalian motor endplates. Br J Pharmacol 100: 487, 1990
DOI
ScienceOn
|
15 |
Sugawara T, Kitamura N, Ohta T, Ito S, Nakazato Y. Inhibitory effects of tacrine and physostigmine on catecholamine secretion and membrane currents in guinea-pig adrenal chromaffin cells. Fundam Clin Pharmacol 12: 279-285, 1998
DOI
ScienceOn
|
16 |
Cena V, Nicolas GP, Sanchez-Garcia P, Kirpekar SM, Garcia AG. Pharmacological dissection of receptor associated and voltagesensitive ionic channels involved in catecholamine release. Neuroscience 10: 1455-1462, 1983
DOI
ScienceOn
|
17 |
Sunaga K, Chuang DM, Ishitani R. Autoradiographic demonstration of an increase in muscarinic cholinergic receptors in cerebellar granule cells treated with tetrahydroaminoacridine. Neurosci Lett 151: 45-47, 1993
DOI
ScienceOn
|
18 |
Kelly KM, Gross RA, Macdonald RL. Tetrahydroaminoacridine (THA) reduces voltage-dependent calcium currents in rat sensory neurons. Neurosci Lett 132: 247-250, 1991
DOI
ScienceOn
|
19 |
Osterrieder W. 9-Amino-1,2,3,4-tetrahydoracridine (THA) is a potent blocker of cardiac potassium channels. Br J Pharmacol 92: 521, 1987
DOI
PUBMED
ScienceOn
|
20 |
Schauf CL, Sattin A. Tetrahydroaminoacridine blocks potassium channels and inhibits sodium inactivation in Myxicola. J Pharmacol Exp Ther 243: 609, 1987
|
21 |
Clarke PBS, Reuben M, El-Bizri H. Blockade of nicotinic responses by physostigmine, tacrine and other cholinesterase inhibitors in rat striatum. Brit J Pharmacol 111: 695-702, 1994
DOI
ScienceOn
|
22 |
Warpman U, Zhang X, Nordberg A. Effect of tacrine on in vivo release of dopamine and its metaboltes in the striatum of freely moving rats. J Pharmacol Expt Ther 277: 917-922, 1996
|
23 |
Burgoyne RD. Mechanism of secretion from adrenal chromaffin cells. Biochem Biophys Acta 779: 201-216, 1984
DOI
ScienceOn
|
24 |
Flynn DD, Mash DC. Multiple in vitro interactions with and differential in vivo regulation of muscarinic receptor subtypes by tetrahydroaminoacridine. J Pharmacol Exp Ther 250: 573, 1989
|
25 |
Szilagyi M, Lau WM. Interaction of tacrine at M1 and M2 cholinoceptors in guinea pig brain. Pharmacology 47: 223-229, 1993
DOI
|
26 |
Gandia L, Borges R, Albillos A, Garcia AG. Multiple calcium channel subtypes in isolates rat chromaffin cells. Pflugers Arch 430: 55-63, 1995
DOI
|
27 |
Garcia AG, Sala F, Reig JA, Viniegra S, Frias J, Fonteriz R, Gandia L. Dihydropyridine Bay-K-8644 activates chromaffin cell calcium channels. Nature 309: 69-71, 1984
DOI
ScienceOn
|
28 |
Uceda G, Artalejo AR, Lopez MG, Abad F, Neher E, Garcia AG. Ca -activated K channels modulated muscarinic secretion in ca chromaffin cells. J Physiol 454: 213-230, 1992
DOI
|
29 |
Farlow M, Gracon SI, Hershey LA, Lewis KW, Sadowsky CH, Dolan-Ureno J. A controlled trial of tacrine in Alzheimer's disease. J Am Med Assoc 268: 2523-2529, 1992
DOI
|
30 |
Lopez MG, Villarroya M, Lara B, Sierra RM, Albillos A, Garcia AG, Gandia L. Q-and L-type Ca2+ channels dominate the control of secretion in bovine chromaffin cells. FEBS Lett 349: 331-337, 1994
DOI
ScienceOn
|
31 |
Eagger SA, Levy R, Sahakian BJ. Tacrine in Alzheimer's disease. Lancet 337: 989-992, 1991
DOI
ScienceOn
|
32 |
Goeger DE, Riley RT. Interaction of cyclopiazonic acid with rat skeletal muscle sarcoplasmic reticulum vesicles. Effect on Ca binding and Ca permeability. Biochem Pharmacol 38: 3995- 4003, 1989
DOI
ScienceOn
|
33 |
Nielsen JA, Mena EE, Williams IH, Nocerini MR, Liston D. Correlation of brain levels of 9-amino-1,2,3,4-tetrahydoracridine (THA) with neurochemical and behavioral changes. Eur J Pharmacol 173: 53, 1989
DOI
ScienceOn
|
34 |
Perry EK, Smith CJ, Court JA, Bonham JR, Rodway BM, Atack JR. Interaction of 9-amino-1,2,3,4-tetrahydoramino-acridine (THA) with human cortical nicotinic and muscarinic receptor binding in vitro. Neurosci Lett 91: 211, 1988
DOI
ScienceOn
|
35 |
Heilbronn E. Inhibition of cholinesterases by tetrahydroaminoacridine. Acta Chem Scand 15: 1386, 1961
DOI
|
36 |
Kao LS, Schneider AS. Calcium mobilization and catecholamine secretion in adrenal chromaffin cells: a Quin 2 fluorescence study. J Biol Chem 261: 4881-4888, 1986
|
37 |
Wakade AR. Studies on secretion of catecholamines evoked by acetylcholine or transmural stimulation of the rat adrenal gland. J Physiol 313: 463-480, 1981
DOI
PUBMED
|
38 |
Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SL, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM, et al. A double-blind, placebo-controlled multicenter study of tacrine fro Alzheimer's disease. The tacrine collaborative group. N Engl J Med 327(18): 1253-1259, 1992
|
39 |
Douglas WW. Secretomotor control of adrenal medullary secretion: synaptin, membrane and ionic events in stimulus-secretion coupling, in Handbook of physiology Sect 7 Vol 6 (Blasko H, Sayers G, Smith AD eds. American Physiology Society, Washington D.C. pp 366-388, 1975
|
40 |
Seidler NW, Jona I, Vegh N, Martonosi A. Cyclopiazonic acid is a specific inhibitor of the Ca -ATPase of sarcoplasimc reticulum. J Biol Chem 264: 17816-17823, 1989
|
41 |
Xiao WB, Nordberg A, Zhang X. Effect of in vivo microdialysis of 1,2,3,4-tetrahydroaminoacridine (THA) on the extracellular concentration of acetylcholine in the striatum of anesthetized rats. J Pharmacol Exp Ther 265: 759-764, 1993
|
42 |
Tallarida RJ, Murray RB. Manual of pharmacologic calculation with computer programs. 2nd Ed New York Speringer-Verlag 132, 1987
|
43 |
Mizobe F, Livett BG. Biphasic effect of eserine and other acetylcholinesterase inhibitors on the nicotinic response to acetylcholine in cultured adrenal chromaffin cells. J Neurochem 39: 379-385, 1982
DOI
|
44 |
Nilsson L, Adem A, Hardy J, Winblad B, Nordberg A. Do tetrahydroaminoacridine (THA) and physostigmine restore acetylcholine release in Alzheimer brains via nicotinic receptors? J Neural Transm 70: 357-368, 1987
DOI
PUBMED
|
45 |
Wada Y, Satoh K, Taira N. Cardiovascular profile of Bay-K-8644, a presumed calcium channel activator in the dog. Naunyn- Schmiedebergs Arch Pharmacol 328: 382-387, 1985
DOI
|
46 |
Stevens DR, Cotman CW. Excitatory actions of tetrahydro-9- aminoacridine (THA) on hippocampal pyramidal neurons. Neurosci Lett 79: 301, 1987
DOI
ScienceOn
|
47 |
Suzuki M, Muraki K, Imaizumi Y, Watanabe M. Cyclopiazonic acid, an inhibitor of the sarcoplasmic reticulum Ca -pump, reduces Ca -dependent K currents in guinea-pig smooth muscle cells. Br J Pharmacol 107: 134-140, 1992
DOI
ScienceOn
|
48 |
Fabianni ME, Kabo P, Story OF. Prejunctional actions of tacrine on autonomic neuroeffector transmission in rabbit isolated pulmonary artery and rat isolated atria. Clin Exp Pharmacol Physiol 19: 631-640, 1992
DOI
|
49 |
Kiefer-Day JS, Campbell HE, Towles J, El-Fakahany EE. Muscarinic subtype selectivity of tetrahydroaminoacridine: possible relationship to its capricious efficacy. Eur J Pharmacol 203: 421-423, 1991
DOI
ScienceOn
|
50 |
Lim DY, Kim CD, Ahn KW. Influence of TMB-8 on secretion of catecholamines from the perfused rat adrenal glands. Arch Pharm Res 15(2): 115-125, 1992
DOI
|
51 |
Sahakian BJ, Coull JT. Tetrahydroaminoacridine (THA) in Alzheimer's disease: an assessment of attention and memory function using CANTAB. Acta Neurol Scand 149(Suppl): 29-35, 1993
|
52 |
Oka M, Isosaki M, Yanagihara N. Isolated bovine adrenal medullary cells: studies on regulation of catecholamine synthesis and release. In: Catecholamines: Basic and Clinical frontiers (Eds. Usdin E, Kopin IJ and Brachas J), Pergamon Press, Oxford, pp. 70-72, 1979
|
53 |
Schramm M, Thomas G, Towart R, Franckowiak G. Novel dihydropyridines with positive isotropic action through activation of Ca channels. Nature 303: 535-537, 1982
DOI
ScienceOn
|
54 |
Sugawara T, Ohta T, Asano T, Ito S, Nakazato Y. Tacrine inhibits nicotinic secretory and current responses in adrenal chromaffin cells. Eur J Pharmacol 319: 123-130, 1997
DOI
ScienceOn
|
55 |
Sahakian BJ, Owen AM, Mornt NJ, Eagger SA, Boddington S, Crayton L, Crockford HA, Crooks M, Hill K, Levy R. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attention and memory function using CANTAB. Psychopharmacology 110: 395-401, 1993
DOI
|
56 |
Drukarch B, Kits KS, Van der Meer EG, Lodder JC, Stoof JC. 9-Amino-1,2,3,4-tetrahydroacridine (THA), an alleged drug for the treatment of Alzheimer's disease, inhibits acetylcholinesterase activity and slow outward K current. Eur J Pharmacol 141: 153-157, 1987
DOI
ScienceOn
|
57 |
Hammer R, Giachetti A. Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization. Life Sci 31: 2992- 2998, 1982
|
58 |
Ladona MG, Aunis D, Gandia AG, Garcia AG. Dihydropyridine modulation of the chromaffin cell secretory response. J Neurochemstry 48: 483-490, 1987
DOI
|